Stay updated on Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page.

Latest updates to the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a software version update for the page rather than changes to the clinical trial details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, indicating a routine update to the page release version.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision tag updated: v3.4.3 replaced by v3.5.0.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.2 was applied and the government funding/operating status notice was removed, with no changes to study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab+Atezolizumab vs Atezolizumab Alone in Lung Cancer Clinical Trial page.